KYOTO, Japan, Nov. 24, 2020 /PRNewswire/ — OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON led this round of investment, reinforcing the cross-company collaboration that began in 2017. The companies continue to […]
Other News
Texas Cardiac Arrhythmia Institute to Hold International Virtual Symposium on Complex Cardiac Arrhythmias
– Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host an international virtual symposium on complex cardiac arrhythmias EPLive 2020, a two-day educational conference, uses live cases as a primary teaching tool AUSTIN, Texas , Nov. 24, 2020 / PRNewswire / – On December 3-4, 2020, the Texas Cardiac […]
Cardiac Center at CHOP Launches New Educational Lecture Series for Healthcare Professionals
PHILADELPHIA, Nov. 24, 2020 /PRNewswire/ — The Cardiac Center at Children’s Hospital of Philadelphia (CHOP) is pleased to announce the launch of Pediatric & Congenital Heart Talks, a free, monthly, video-based educational resource for clinical and research professionals in pediatric cardiology. Hosted by Jack Rychik, MD, director of the Fetal Heart Program at CHOP, and featuring discussions with world-class experts […]
Medtronic Reports Second Quarter Fiscal 2021 Financial Results
– Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic – Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2021, which ended October 30, 2020. The company reported second quarter worldwide revenue of $7.647 billion, […]
MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients
NYON, Switzerland, Nov. 24, 2020 /PRNewswire/ — MedAlliance has announced completion of patient enrolment in the ISABELLA Clinical Trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodialysis. SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained […]
Hancock Jaffe’s VenoValve(R) Results Featured in Journal of Vascular Surgery Venous and Lymphatic Disorders
Preliminary First-in-Human Study Results Published in Peer-Reviewed Journal IRVINE, CA / ACCESSWIRE / November 23, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Journal of Vascular Surgery Venous and Lymphatic Disorders, published a paper featuring interim […]
CARDIAWAVE HAS BEEN GRANTED AUTHORIZATION BY THE ANSM
Paris, November 17th, 2020 The French MedTech Cardiawave has been granted authorization by the Agence Nationale de Sécurité du Médicament et des produits de santé – ANSM (French National Agency for Health Products Safety) on October 20th to extend its clinical trial in France and treat patients with calcific aortic […]
Vvital Biomed Announces Stellar Advisory Board
The advisory board members bolster the Vvital team to develop a game-changing mitral valve repair solution Misgav, Israel – 24 November 2020 – Vvital Biomed (“Vvital”), a portfolio company of The Trendlines Group Ltd. (SGX: 42T; OTCQX: TRNLY), a leading Israel- and Singapore-based investment group focused on high-growth medical and […]
CardiacVascularNews talks remote case support and Thanksgiving with Jenn Fried, CEO of ExplorerSurgical.
Listen to Jenn Fried, CEO of Explorer Surgical talk about the move to digital, remote case support, workflows, and what’s on her table this year for Thanksgiving.
Rapid Medical Expands Comaneci™ CE Mark Indication to Include Vasospasm Treatment
Comaneci is the first adjustable mesh device indicated for the endovascular treatment of vasospasm YOKNEAM, Israel, Nov. 23, 2020 /PRNewswire/ — Rapid Medical, a company focused on the development of next-generation neurovascular devices, has announced CE Mark approval for the expanded indication of Comaneci to treat cerebral vasospasm. Comaneci is the first adjustable remodeling […]



